bims-traimu Biomed News
on Trained immunity
Issue of 2026–11–15
thirteen papers selected by
Yantong Wan, Southern Medical University



  1. Cells. 2026 Nov 05. pii: 2022. [Epub ahead of print]15(21):
      Metabolic dysfunction-associated steatohepatitis (MASH) involves hepatocellular injury, myeloid activation, and fibrotic remodeling that may resolve unevenly following metabolic improvement. Whether previous injury leaves a functionally consequential innate immune imprint remains unresolved. This review evaluates trained immunity as a candidate mechanism linking exposure history to persistent hepatic myeloid responsiveness. We distinguish continued activation by lipotoxic and stromal signals from responses retained after stimulus withdrawal, macrophage replacement, and hematopoietic progenitor programming. Evidence from Kupffer cells, monocyte-derived macrophages, and lipid- or scar-associated populations reveals divergent inflammatory, efferocytosis, and matrix remodeling functions. Receptor-dependent lipid handling intersects with glycolysis, citrate-derived acetyl-CoA, serine and one-carbon metabolism, NAD+ availability and histone methylation, acetylation, and lactylation. These pathways explain how metabolic inputs regulate inflammatory competence, but their alteration during active MASH does not establish immune memory. Rested monocyte training models provide stronger temporal evidence than most disease-specific studies, whereas protective TREM2-dependent responses caution against indiscriminate suppression of disease-associated macrophages. Establishing a contribution to MASH recurrence requires lineage-resolved investigations spanning injury, regression, and rechallenge, with interventions separating memory establishment, maintenance, and effector output. If exposure-dependent myeloid memory contributes causally to MASH recurrence, targeting maladaptive responsiveness could complement injury control while preserving hepatic repair.
    Keywords:  epigenetic memory; hepatic macrophages; immunometabolic reprogramming; metabolic dysfunction-associated steatohepatitis; trained immunity
    DOI:  https://doi.org/10.3390/cells15212022
  2. Clin Epigenetics. 2026 Aug 12. pii: 207. [Epub ahead of print]18(1):
      Histone lactylation, particularly H3K18 lactylation (H3K18la), has emerged as a lactate-derived epigenetic modification that links metabolic reprogramming to sustained chromatin states. Here, we advance a hypothesis that the lactate-p300-H3K18la axis functions as an epigenetic memory code, converting transient glycolytic signals into persistent transcriptional responsiveness in innate immune cells-a mechanism we term "context-dependent lactylation memory." We integrate evidence from three converging domains: the persistence of lactylation at trained immune loci, the requirement of H3K18la for trained immunity demonstrated in recent BCG vaccination studies, and the hypoxic, glycolytic microenvironment of the atherosclerotic plaque. We propose that cardiovascular risk factors stabilize HIF-1α, which drives glycolytic reprogramming and sustained lactate production. Lactate-derived lactyl-CoA then serves as a substrate for p300/CBP-mediated H3K18la deposition at immune gene regulatory elements, creating a poised chromatin state that sustains innate immune hyperresponsiveness. This cascade provides a mechanistic explanation for residual inflammatory risk, the observation that elevated cardiovascular events persist despite optimal lipid-lowering therapy. The framework is constrained by the context-dependent duality of lactylation, whereby cell type, lysine site, and metabolic flux direction jointly determine whether the modification drives pro-inflammatory or reparative outcomes. We delineate testable predictions that define a roadmap for empirical validation or refutation of the lactate-lactylation memory hypothesis in human CHD.
    Keywords:  Atherosclerosis; Coronary heart disease; H3K18 lactylation; HIF-1alpha; Histone lactylation; Immunometabolism; Residual inflammatory risk; Trained immunity
    DOI:  https://doi.org/10.1186/s13148-026-02224-8
  3. J Clin Anesth. 2026 Nov 09. pii: S0952-8180(26)00251-5. [Epub ahead of print]116 112372
      
    Keywords:  BCG; Microglia; Perioperative neurocognitive disorders; Prevent; Trained immunity
    DOI:  https://doi.org/10.1016/j.jclinane.2026.112372
  4. Semin Immunopathol. 2026 Nov 13. pii: 25. [Epub ahead of print]48(1):
      Chronic endometritis (CE) is a persistent, low-grade inflammatory condition of the endometrium, typically caused by microbial infections. CE is often asymptomatic, leading to frequent underdiagnosis. It is frequently identified during the assessment of causes for infertility. Even after resolving the infectious etiology by antibiotic treatment, infertility persists in a number of patients. Emerging evidence from chronic inflammatory diseases affecting epithelial tissues, e.g., in the gut, suggests that inflammatory conditions can induce long-lasting epigenetic changes, e.g., in innate immune cells. Notably, tissues outside the immune system can also retain memory of inflammatory events and environmental insults via epigenetic modifications. This review summarizes how epigenetic changes can affect endometrial function, drawing on current knowledge of CE. It also discusses how inflammation prompts these changes. We propose that persistent epigenetic memory in both immune and non-immune endometrial cells plays a crucial role in sustaining CE-associated adversities, such as infertility. Future research should focus on pinpointing specific epigenetic patterns in CE and exploring how inflammation-induced memory leads to cellular dysfunction in the endometrium. Understanding these mechanisms will advance CE diagnosis and open doors to new treatment options for infertility, focusing on reversing the inflammatory memory retained upon treatment of CE.
    Keywords:  chronic endometritis; epigenetic memory; infertility; inflammation; trained functionality; trained immunity
    DOI:  https://doi.org/10.1007/s00281-026-01093-w
  5. Cells. 2026 Oct 31. pii: 1995. [Epub ahead of print]15(21):
      Atherosclerotic carotid plaques are shaped by years of interaction between systemic risk factors, hematopoietic conditioning, vascular injury, and local immune responses, yet conventional assessment captures only a limited snapshot of this biological history. This review introduces the concept of the "immunological biography" of the carotid plaque and examines how trained innate immunity, macrophage state and defective resolution, adaptive immune memory, T- and B-cell clonal selection, and spatially organized immune niches contribute to plaque heterogeneity and vulnerability. The literature was identified through a structured PubMed search complemented by reference screening, with emphasis on human carotid tissue, paired blood-plaque studies, immune-repertoire analyses, and single-cell and spatial technologies. Current evidence indicates that immune-cell abundance alone incompletely characterizes plaque biology: functional state, antigen experience, clonality, tissue localization, and interactions with vascular and stromal cells provide additional levels of biological information. We propose the Carotid Plaque Immune Phenotype (CPIP) as an integrative framework linking systemic immune history with cellular state, clonal architecture, spatial organization, and clinically relevant plaque features. Combining circulating biomarkers with tissue-resolved immune profiling may ultimately improve biological phenotyping of carotid atherosclerosis and provide a framework for prospective studies linking plaque immune architecture with cerebrovascular events.
    Keywords:  T-cell clonality; adaptive immunity; carotid atherosclerosis; carotid plaque; immune memory; plaque vulnerability; single-cell RNA sequencing; spatial transcriptomics; trained immunity; vascular inflammation
    DOI:  https://doi.org/10.3390/cells15211995
  6. Int J Mol Sci. 2026 Oct 28. pii: 9666. [Epub ahead of print]27(21):
      Obesity reshapes immune function across adipose tissue, circulation, and hematopoietic compartments. Weight reduction improves cardiometabolic health, yet emerging evidence indicates that prior obesity can leave persistent cellular, transcriptional, and epigenetic changes. Whether nutrition can reverse this biological imprint remains uncertain. We conducted a critical narrative review informed by structured searches of PubMed/MEDLINE, the Cochrane Library, and Epistemonikos, complemented by backward and forward citation tracking. We prioritized mechanistic human studies, controlled dietary interventions, longitudinal weight-loss studies, and experiments that tested persistence after stimulus withdrawal or response to re-exposure. Evidence was interpreted according to biological compartment and study design rather than pooled statistically. Obesogenic exposures can alter innate immune metabolism, inflammasome signaling, hematopoiesis, and chromatin states. Animal studies provide the strongest evidence that these changes can persist after weight normalization and amplify responses during weight regain. Human studies show incomplete normalization of adipose immune states, persistent adipocyte programs, and durable methylation changes in T lymphocytes after weight loss. Dietary interventions can lower inflammatory tone and modify immune metabolism, microbial metabolites, and lipid mediator pathways, but no dietary pattern has been shown to erase established obesity-associated immune memory in humans. An evidence map built on a core set of 47 studies showed that experimental work dominates the induction, persistence and re-challenge domains, whereas human evidence clusters in post-weight-loss remodelling and dietary modulation; human re-challenge data were absent and no study provided a direct test of reversal in humans. Obesity-associated immunometabolic memory appears to be distributed across hematopoietic, immune, adipose, stromal, and microbial compartments. Nutrition can modulate mechanisms implicated in this persistence, but human evidence of reversal is lacking, and whether pharmacologically induced weight loss leaves a comparable imprint has not been tested. Mechanistic trials should separate energy deficit, diet composition, adiposity change, and weight-loss modality and include a weight-stable follow-up and functional re-challenge where feasible.
    Keywords:  adipose tissue; epigenetic memory; immunometabolism; inflammation; nutrition; obesity; trained immunity; weight loss
    DOI:  https://doi.org/10.3390/ijms27219666
  7. J Innate Immun. 2026 Nov 10. pii: adhag005. [Epub ahead of print]
       BACKGROUND: Allergic rhinitis (AR) is a prevalent recurrent upper airway inflammatory disorder. The lack of clarity on chronicity driving mechanisms hinders the development of precise treatments for severe, persistent allergic rhinitis.
    OBJECTIVE: This study aimed to uncover the epigenetic and metabolic basis of sustained AR inflammation and identify key cellular drivers and therapeutic targets for refractory AR.
    METHODS: We combined a two hit house dust mite (HDM) induced chronic AR mouse model and clinical samples from severe chronic AR patients. Integrated epigenetic profiling, metabolic assays, eosinophil depletion, IL 33-ST2 blockade, and clinical correlation analyses were performed to characterize pathogenic eosinophil programming.
    RESULTS: A long lived, epigenetically and metabolically programmed eosinophil subset drove chronic AR. Post acute inflammation resolution, eosinophil precursors exhibited elevated chromatin accessibility at Alox5, Il4ra, Pparg, and Csf2rb, forming persistent epigenetic imprinting. These eosinophils underwent PPARγ dependent fatty acid oxidation (FAO) reprogramming, with prolonged survival, reduced apoptosis, and heightened sensitivity to IL 33/C5a, promoting robust IL 4/IL 13 and LTC4 release. Targeted eosinophil depletion or IL 33-ST2 blockade relieved nasal inflammation and allergic symptoms. Consistently, severe AR patient eosinophils displayed enhanced FAO and ALOX5 accessibility, which positively correlated with LTC4 production.
    CONCLUSION: Eosinophil innate immune memory via epigenetic and metabolic reprogramming sustains chronic AR. This conserved pathogenic signature provides a candidate biomarker for patient stratification and novel therapeutic targets for refractory upper airway allergy.
    DOI:  https://doi.org/10.1159/jin/adhag005
  8. Nat Commun. 2026 10 15. pii: 11667. [Epub ahead of print]17(1):
      Endothelial dysfunction contributes to multi-organ injury in sepsis, but the underlying mechanisms remain incompletely understood. Here we show that endothelial ubiquitin-specific protease 28 (USP28) is increased in patients with sepsis and in male mice in a murine polymicrobial sepsis model. Mechanistically, USP28 stabilizes non-muscle myosin heavy chain IIA (NMMHC IIA) by removing K48-linked ubiquitination at K1413. Moreover, NMMHC IIA promotes interferon-α/β receptor 1 (IFNAR1) trafficking to the plasma membrane, enhancing IFNAR1/signal transducer and activator of transcription 1 (STAT1) signaling and endothelial necroptosis. In turn, STAT1 transcriptionally increases USP28 expression, forming a positive feedback loop. Endothelial USP28 deletion or pharmacological inhibition attenuates sepsis-induced multi-organ injury, whereas USP28 overexpression exacerbates it. Conversely, endothelial NMMHC IIA or IFNAR1 overexpression largely abrogates the protection conferred by USP28 deficiency in septic male mice. These findings identify a USP28-NMMHC IIA axis that promotes endothelial necroptosis and multi-organ injury in sepsis through IFNAR1/STAT1 signaling.
    DOI:  https://doi.org/10.1038/s41467-026-78666-8
  9. J Immunol. 2026 Nov 02. pii: vkag304. [Epub ahead of print]215(11):
      Interleukin-1 beta (IL-1β) is a highly proinflammatory cytokine whose synthesis and cleavage are tightly regulated. It is important for protection from several infections, but can also play a damaging role in autoimmune and autoinflammatory diseases. While pattern recognition receptor activation leads to potent induction of IL-1β, its production at steady state and the nature of cells that make IL-1β in vivo is not fully understood. Therefore, tools to detect early transcription of IL-1β-producing cells and permanent labeling of the lineage can provide critical insights into the functioning of the innate immune system. Here, we describe a novel IGNITE (IL-1β-Guided Neon green with Irreversible tdTomato Expression) mouse, a dual-reporter model that enables real-time visualization of Il1b transcription via mNeonGreen and permanent lineage tracing through Cre-dependent tdTomato expression. Using this system, we tracked Il1b-associated mNeonGreen and subsequent tdTomato expression both in vitro and in vivo. Unexpectedly, we identified heterogeneous tdTomato cell populations across multiple tissues in unmanipulated IGNITE mice, suggesting that a subset of myeloid cells transcribes Il1b at homeostasis without needing an experimentally driven activation of pattern recognition receptors. Neutrophils, monocytes, macrophages, and dendritic cells had different tdTomato+ proportions, suggesting varied encounters with inflammatory stimuli. Transcriptomic analysis revealed an unexpected dichotomy in the induction of NF-κB- versus IRF-mediated genes between tdTomato+ and tdTomato- conventional dendritic cell type 2 populations, following Toll-like receptor stimulation. Thus, the IGNITE mouse provides a powerful new tool for studying Il1b transcriptional dynamics and fate mapping, offering new insights into the spatial and temporal regulation of innate immune responses.
    Keywords:  dual-reporter; gene regulation; inflammation; interleukin-1β
    DOI:  https://doi.org/10.1093/jimmun/vkag304
  10. Nat Commun. 2026 10 12. pii: 11556. [Epub ahead of print]17(1):
      Investigation of crosstalk between antagonistic pro- and anti-inflammatory cytokines has focused on mechanisms and functional consequences of cross-inhibition. Here, we investigate cross-regulation between proinflammatory tumor necrosis factor (TNF) and anti-inflammatory interleukin-4 (IL-4) in primary human monocytes and in a skin wound-healing model. Surprisingly, TNF functioned mainly as a costimulator of IL-4-induced gene expression, whereas IL-4 selectively inhibited the TNF-induced IFN response, leaving inflammatory gene expression mostly intact. TNF and IL-4 synergistically induced gene sets that are important in the regulation of inflammation and tissue repair, which were highly induced during the phase of wound healing when these cytokines are co-expressed. Crosstalk between TNF and IL-4 was mediated by epigenetic chromatin-mediated mechanisms associated with cooperation between NF-κB and STAT6 transcription factors, erasure of negative histone mark H3K27me3, and selective inhibition of IRF1. These results identify a mechanism for expansion of the IL-4 response and highlight the complexity of crosstalk between antagonistic cytokines, including cooperation for select gene responses that are important for immune responses and tissue repair.
    DOI:  https://doi.org/10.1038/s41467-026-78528-3
  11. Sci Adv. 2026 Nov 13. 12(46): eaek8053
      Interleukin-6 (IL-6) is a pleiotropic cytokine that drives macrophage functions ranging from tissue homeostasis to inflammation, yet how STAT3 specifies these divergent outcomes remains unclear. By integrating transcriptomic and epigenomic profiling with selective STAT3 degradation, we show that STAT3 controls IL-6-induced epigenomic remodeling and restrains a latent STAT1-associated interferon program in human macrophages. Graded STAT3 chromatin recruitment scales with locus-specific H3K27ac deposition and transcriptional output across homeostatic and inflammatory programs. STAT3 degradation permits STAT1 recruitment at a subset of regulatory regions and engages a delayed amplification loop that is partially dependent on STING and type I IFN signaling. In severe COVID-19, monocytes exhibit exaggerated STAT3-associated inflammatory signatures together with attenuated STAT1-associated interferon responses, consistent with a skewed STAT3-STAT1 balance. These findings define a framework in which STAT3 calibrates IL-6-induced chromatin output while maintaining pathway fidelity by limiting STAT1 cross-talk.
    DOI:  https://doi.org/10.1126/sciadv.aek8053
  12. Nat Commun. 2026 11 06. pii: 11497. [Epub ahead of print]17(1):
      Neutrophil extracellular trap formation is a central innate immune defence mechanism that depends on NADPH oxidase-driven reactive oxygen species production. How NADP⁺ availability is regulated during neutrophil activation remains unclear. Using integrated lipidomic, biochemical and functional analyses in human neutrophils, we identify NAD kinase, the sole enzyme responsible for NADP⁺ synthesis, as a direct lipid-regulated effector downstream of phospholipase D1. Neutrophil activation induces rapid, phospholipase D1-dependent production of phosphatidic acid and phosphatidylinositol 4,5-bisphosphate, which bind and activate NAD kinase. The resulting cytosolic NADP⁺ is reduced to NADPH by the oxidative pentose phosphate pathway and consumed by NADPH oxidase during neutrophil extracellular trap formation. Pharmacological or genetic disruption of phospholipase D1 suppresses NAD kinase activity, depletes NADP⁺ and impairs neutrophil extracellular trap formation independently of direct NADPH oxidase inhibition. These findings define a lipid-metabolic axis coupling phospholipase D1-driven membrane remodelling to NADP⁺ availability and innate immune function.
    DOI:  https://doi.org/10.1038/s41467-026-79319-6
  13. Nature. 2026 Nov 11.
      Disconnects between in vitro and in vivo results in experimental biology have long been recognized as potential hurdles to understanding health and disease. A prototypical example of such a disconnect is the NLRP3 inflammasome, which mediates inflammation in diverse settings of disease and protective immunity1,2. Activation of the NLRP3 inflammasome in vitro requires two signals: (1) priming by pathogen-associated molecular patterns such as bacterial lipopolysaccharides and (2) activation by molecules that disrupt cellular homeostasis1,3. By contrast, the NLRP3 inflammasome in vivo is activated by lipopolysaccharide alone. The mechanisms that underlie the difference between in vitro and in vivo activation of the NLRP3 inflammasome are undefined. Here we report that extracellular matrix (ECM) stiffness is a determinant of NLRP3 activities and that in vitro systems using physiological ECM stiffness enable one-signal in vivo-like NLRP3 activities to occur in human and mouse phagocytes. Physiological ECM stiffness induced expression of the transcription factor NRF2, which was found to be necessary for one-signal NLRP3 activation. Mechanistically, we identify Panx1 as an NRF2-regulated gene that promotes NLRP3 activity. Macrophages derived from the stiff matrix of the bone-osteoclasts-had reduced NRF2 levels and impaired NLRP3 activity. Moreover, alveolar macrophages from patients with pulmonary fibrosis displayed reduced NRF2 activity. Finally, NRF2 was required for antitumour immunity induced by cancer vaccines consisting of NLRP3 agonistic adjuvants. These findings indicate that NRF2 may be a transcriptional checkpoint that controls NLRP3 inflammasome activity.
    DOI:  https://doi.org/10.1038/s41586-026-11324-7